Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
immunology and microbiology
Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women
Scandinavian Journal of Infectious Diseases, Volume 42, No. 6-7, Year 2010
Notification
URL copied to clipboard!
Description
Although infections with multiple human papillomavirus (HPV) types have been reported widely, more information is needed on the occurrence of the different types. We determined the distribution of seroprevalences to multiple HPV types in Finland and Uganda to compare the epidemiology of the different HPV types in the 2 populations. Serum samples were obtained from 2784 Finnish and 1964 Ugandan women (mean ages 22 y and 25 y, respectively) of whom 44% and 57%, respectively, had antibodies to at least 1 of the 7 HPV types (6, 11, 16, 18, 31, 33, 45) tested (p < 0.001). Multiple HPV antibody positivity was common. HPV45-seropositive Finns had a higher risk of having antibodies to other high-risk HPV types: HPV18 (odds ratio (OR) 10.9), HPV31 (OR 6.1), HPV33 (OR 12.2), than their Ugandan counterparts: HPV18 (OR 3.4), HPV31 (OR 2.2), HPV33 (OR 3.3). Increased estimates for being double antibody-positive were also noted among HPV18- and HPV16-seropositive women, but there were no major differences between HPV16-seropositive Finns and Ugandans. In addition to biological and behavioural factors, iatrogenic and societal factors (screening vs no screening) may also result in the different occurrence of infections with the high-risk HPV types in Finland and Uganda. © 2010 Informa UK Ltd.
Authors & Co-Authors
Namujju, Proscovia Bazanya
Finland, Helsinki
Terveyden ja Hyvinvoinnin Laitos
Uganda, Entebbe
Uganda Virus Research Institute
Surcel, Heljä Marja
Finland, Helsinki
Terveyden ja Hyvinvoinnin Laitos
Kirnbauer, Reinhard
Austria, Vienna
Medizinische Universität Wien Universitätsklinik Für Dermatologie
Kaasila, Marjo
Finland, Helsinki
Terveyden ja Hyvinvoinnin Laitos
Banura, Cecily
Uganda, Kampala
School of Medicine, Makerere University College of Health Sciences
Sweden, Stockholm
Karolinska Institutet
Byaruhanga, Romano Nkumbwa B.
Uganda
St. Francis Hospital
Sweden, Stockholm
Karolinska Institutet
Muwanga, Moses
Uganda
Entebbe Hospital
Mbidde, Edward Katongole
Uganda, Entebbe
Uganda Virus Research Institute
Koskela, Pentti U.
Finland, Helsinki
Terveyden ja Hyvinvoinnin Laitos
Lehtinen, Matti O.
Finland, Helsinki
Terveyden ja Hyvinvoinnin Laitos
Finland, Tampere
Tampere University
Statistics
Citations: 12
Authors: 10
Affiliations: 8
Identifiers
Doi:
10.3109/00365540903582426
ISSN:
00365548
Research Areas
Cancer
Study Design
Case-Control Study
Study Locations
Uganda
Participants Gender
Female